When experts disagree: The cholesterol standoff

Patient Care

Volumn 30, Issue 20, 1996, Pages 62-91

  Pennachio, Dorothy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005330185     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Heitzer T, Yla-Herttuala S, Luoma J, et al: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: Role of oxidized LDL. Circulation 1996;93:1346-1353.
2. National Cholesterol Education Program: Second Report of the Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Bethesda, National Heart, Lung, and Blood Institute. NIH publication No. 93-3095, 1993.
3. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993;269:505-510.
4. American College of Physicians: Clinical Guideline, part 1: Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996;124:515-517.
5. Garber AM, Browner WS, Hulley SB: Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med 1996;124:518-531.
6. Avins AL, Browner WS: Lowering risk without lowering cholesterol: Implications for national cholesterol policy. Ann Intern Med 1996;125:502-506.
7. LaRosa JC: Cholesterol agonistios, editorial. Ann Intern Med 1996;124: 505-508.
8. Task Force on Risk Reduction, American Heart Association: Cholesterol screening in asymptomatic adults: No cause to change, editorial. Circulation 1996; 93:1067-1068.
9. U.S. Preventive Services Task Force: Screening for high blood cholesterol and other lipid abnormalities, in Guide to Clinical Preventive Services, ed 2. Baltimore, Williams & Wilkins, 1996, pp 15-38.
10. Allen JK, Young DR, Blumenthal RS, et al: Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease: Application of the second adult treatment panel guidelines. Arch Intern Med 1996;156:1654-1660.
11. United States General Accounting Office: Cholesterol Treatment: A Review of the Clinical Trials Evidence. GAO publication No. GAO/PEMD-96-7. Washington, D.C., United States General Accounting Office, 1996.
12. American Academy of Pediatrics Committee on Nutrition: Statement on cholesterol. Pediatrics 1992;90:469-473.
13. Lambert M, Lupien P, Gagne C, et al: Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin. Pediatrics 1996;97:619-628.
14. Bao W, Srinivasan SR, Wattigney WA, et al: Usefulness of childhood low-density linoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study. Arch Intern Med 1996;156:1315-1320.
15. Shepherd J, Cobbe SM, Ford I, et al for the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease wrth pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.
16. Ramsay LE, Yeo WW, Jackson PR: Dietary reduction of serum cholesterol concentration: Time to think again. BMJ 1991;303:953-957.
17. Caggiula AW, Watson JE, Kuller LH, et al: Cholesterol-lowering intervention program: Effect of the Step I diet in community office practices. Arch Intern Med 1996;156:1205-1213.
18. Williams PT: High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med 1996;334:1298-1303.